Valsartan/Amlodipine Orotate

缬沙坦/氨氯地平乳清酸盐

Report date: 2026/02/05 10:48:33

Base Information

Drug NameValsartan/Amlodipine Orotate
Drug Alias NameOrosartan
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/07/30
Country/TerritorySouth Korea
CombinationsYes ValsartanAmlodipine Orotate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A